Introduction {#S0001}
============

Connexin 43 (Cx43), also called Gjp1a, is the predominant protein located in intercellular plasma-membrane channels that directly connect the cytoplasm of adjacent Sertoli cells, between Sertoli cells and germ cells, and between Leydig cells \[[@CIT0001]\]. They allow the direct exchange of molecules with molecular mass up to 1 kDa. Such intercellular communication plays an essential role in many physiological processes including cell synchronization proliferation, differentiation, apoptosis and metabolic coordination of avascular organs \[[@CIT0002], [@CIT0003]\]. In mature rats, the strongest Cx43 expression appears in stages I-VIII of the seminiferous epithelium cycle \[[@CIT0004], [@CIT0005]\]. In mice with mosaic mutation and partial deletion of the long arm of the Y chromosome, severe spermatogenic impairment is associated with the loss of Cx43 immunoreactivity. This suggests that Cx43-based gap junctions play a role in spermatogenesis \[[@CIT0006]\].

Thyroid hormone shortens the time when Sertoli cells divide postnatally. Neonatal hyperthyroidism decreased adult Sertoli cell populations by premature cessation of their proliferation and stimulated their maturation events such as seminiferous tubule canalisation \[[@CIT0007]--[@CIT0009]\]. Several recent studies have demonstrated that the inhibitory effect of T3 on Sertoli cell proliferation is associated with increased levels of Cx43 in postnatal testis \[[@CIT0010]--[@CIT0012]\]. Mice congenitally lacking Cx43 develop seminiferous tubules containing fewer germ cells and a vacuous lumen in the postnatal period of life \[[@CIT0013]\].

A natural decrease in the incidence of Cx43 positive seminiferous tubule cross-sections from about 90% to 60% was reported to occur during progression of normal tubule maturation in rodents \[[@CIT0004], [@CIT0014]\]. This decline may correspond to a natural decline in the expression of thyroid hormone receptor (TR) in rat Sertoli cells. TR expression is high after birth, gradually decreases by between pnd 15 and 20 and is minimal thereafter \[[@CIT0015]--[@CIT0017]\]. Gilleron *et al*. \[[@CIT0010]\] have suggested that Cx43 might mediate the stimulatory effect of thyroid hormone on Sertoli cell maturation *in vitro*.

The influence of T3 systemic administration on Cx43 expression during seminiferous tubule maturation has not been investigated yet and is the subject of the present study.

Material and methods {#S0002}
====================

Animals and treatments {#S20003}
----------------------

Pregnant Wistar rats were obtained from the Department of Animal Facilities, Medical University of Lodz (Poland). On the day of birth (day 1) the litters were designated at random to treatment and control groups. Each group, containing 5 animals, was kept in a separate cage together with one lactating female. Animals were maintained at a stable temperature (22°C) and diurnal light-dark cycles (12L: 12D) with free access to food and water. The experiment was performed in accordance with Polish legal requirements, under the license given by the Commission of Animal Ethics at the Medical University of Lodz, Poland.

Male pups received daily subcutaneous injections of 100 µg T3/kg body weight (b.w.) (Sigma-Aldrich, St. Louis, USA), dissolved in 0.025 N NaOH in saline solution \[[@CIT0007], [@CIT0017]\]. Injections of T3 took place from pnd 1 to 5 followed by daily injections with solvent until pnd 15 (transient T3 administration -- tT3), or pups were continuously injected with T3 from pnd 1 until 15 (continuous T3 administration -- cT3). Animals were autopsied on pnd 16. The control group received daily subcutaneous injections of 0.025 N NaOH in saline solution at the same vo lume (0.1 ml) until pnd 15. To estimate the degree of maturational changes in the seminiferous epithelium in experimental rats, six adult untreated rats were euthanized on pnd 50 and evaluated.

Before autopsy, rats were anaesthetized with Thiopental (Sandoz GmbH, Kundl, Austria) and Fentanyl WZF (Polfa, Pabianice, Poland) and weighed. Blood samples were taken by cardiac puncture. Paired testes weight was measured at autopsy. The relative paired testes weight was calculated as paired testes weight/10 g b.w. The right testis of each rat was fixed in Bouin's fluid and embedded in paraffin.

Hormone assays {#S20004}
--------------

After centrifugation of the blood, the serum was collected, frozen and stored at −20°C until assayed. All samples were measured in the same assay. Free iodothyronine 3 (fT3) concentration was determined by microparticle enzyme immunoassay (MEIA) (Abbott Diagnostics, Illinois, USA) with a sensitivity of 1.0 pg/ml. Rat follicle-stimulating hormone (rFSH) concentrations were determined by double antibody radioimmunoassay (Ortho-Clinical Diagnostics, Amersham, UK) with a sensitivity of 1.0 ng/ml. Concentrations of testosterone and oestradiol were determined by competitive immunoassay technique (Ortho-Clinical Diagnostics, Amersham, UK). The sensitivities were 0.03 nmol/l for testosterone and 10.0 pmol/l for oestradiol.

Seminiferous tubule morphometry {#S20005}
-------------------------------

Sections 4 µm thick from equatorially cut testes were stained with haematoxylin (Bio-Optica, Milano, Italy) and eosin (Serva, Heidelberg, Germany). The diameters of 100 randomly selected tubular cross-sections of seminiferous tubules for each animal were analysed using image analysis software LxAND v3.60HM (Logitech, Lodz, Poland).

The total length of the seminiferous tubule (*L*) was calculated using the transformed standard equation for a tube model (*L* = *V*/π*r* ^2^) \[[@CIT0018]\], where *V* was seminiferous tubule volume and *r* radius of the tubule. The first step was to evaluate the volume density (*V*ν) of the seminiferous tubules by point counting \[[@CIT0019]\]. Ten randomly selected sections of the testis of each animal were examined using image analysis software which superimposed a square lattice containing 441 intersections on the microscopic image. The number of intersections on the examined structure over the entire tissue section was counted by a predetermined and systematic movement of sections across the grid without overlap. *V*ν was obtained by dividing the sum of the points falling on the tubular cross-sections by the total number of points over the tissue. The results were expressed as a percentage. The volume of the seminiferous tubules (*V*) was subsequently determined by multiplying *V*ν by fresh testis volume (*VT*): *V* = *V*ν × *VT*. The specific gravity of testicular tissue is about 1.0, so the values obtained for testicular weight were taken as being equivalent to fresh testicular volume.

Germ cell degeneration {#S20006}
----------------------

Toluidine blue (Bio-Optica, Milano, Italy) staining was performed for the identification of germ cell degeneration in paraffin sections \[[@CIT0020], [@CIT0021]\]. Germ cell degeneration was expressed as a percentage of tubular cross-sections containing degenerating cells, identified as having strongly condensed, darkly stained nuclei in toluidine-blue-stained sections. 100 tubular cross-sections per animal were scored. All counts were performed at 1000× magnification in the light microscope (Nikon, Eclipse E600, Tokyo, Japan).

Immunohistochemical staining for Cx43 expression {#S20007}
------------------------------------------------

Testes sections (4 µm thick) were placed onto slides coated with 0.1% poly-L-lysine solution (Sigma-Aldrich, St. Louis, USA), then dewaxed and dehydrated in xylene and graded ethanols, and rehydrated. To optimize immunohistochemical staining, the samples were exposed to an antigen retrieval procedure by microwaving (800 W) tissue sections in 0.01 M citrate buffer (pH 6.0). Endogenous peroxidase activity was blocked by incubating sections in 0.03% H~2~O~2~. A mouse monoclonal antibody raised against amino acids 241-254 within the cytoplasmic domain of Cx43 of rat origin (Santa Cruz Biotechnology Inc., Santa Cruz, USA) was used. Sections were incubated with the primary antibody (1: 25) for 30 min. To reduce background staining, the primary antibody was diluted in a diluent with background reducing components (Dako, Glostrup, Denmark). A commercially available EnVision system-HRP kit (Dako, Glostrup, Denmark), based on a horseradish peroxidase labelled polymer, was used as a secondary reagent. After each step, the sections were rinsed and incubated twice for 5 min in Tris Buffered Saline with Tween-20 pH 7.4 (Sigma-Aldrich, St. Louis, USA). The colour reaction was developed using 3,3'-diaminobenzidine chromogen solution, which resulted in a brown-coloured precipitate at the antigen site. Then the sections were counterstained with Mayer's haematoxylin (Bio-Optica, Milano, Italy). For the negative control the sections were incubated with non-immune serum instead of the primary antibody.

Considering that the seminiferous epithelium cycle is already established from pnd 15 in rats \[[@CIT0022]\], the evaluation of Cx43 expression was performed in tubular cross-sections containing the same germ cell associations. Based on the abbreviated classification described by Russell *et al*. \[[@CIT0023], [@CIT0024]\] for immature rats with a paucity of spermatids, two cell associations were selected. Both contain type A spermatogonia and single pachytene spermatocytes but association 1 contains type B spermatogonia, i.e. it represents stages V/VI of the adult seminiferous epithelium cycle. In turn, association 2 contains preleptotene spermatocytes, i.e. it represents stages VII/VIII. Localization of Cx43 antigen was estimated qualitatively in the light microscope (Nikon, Eclipse E600, Tokyo, Japan) at 1000× magnification. One hundred tubule cross-sections with equal proportions of both associations were estimated qualitatively. The percentages of seminal tubules revealing a positive immunohistochemical reaction for the presence of Cx43 in each rat were calculated.

Statistical analysis {#S20008}
--------------------

Distribution of the data was analysed using the Shapiro-Wilk test. The parametric data were presented as mean ± standard deviation and were analysed using one-way ANOVA followed by the least significant differences (LSD) as a *post hoc* test. Differences were considered significant at *p* \< 0.05.

Results {#S0009}
=======

Hormone levels {#S20010}
--------------

In the control group, the fT3 serum level was 2.01 ±0.7 pg/ml, and was 2.6 times higher in tT3 (5.3 ±2.7, *p* \< 0.05), and 11.9 times higher in cT3 (23.9 ±2.7 pg/ml, *p* \< 0.001). Serum rFSH in the control group was 3.3 ±1.4 ng/ml and did not differ significantly in tT3 (5.7 ±4.9) or in cT3 (6.7 ±4.5). The serum level of testosterone was 0.9 ±0.2 nmol/l in the control group and did not differ either in tT3 (1.0 ±0.2) or in cT3 (1.1 ±0.5). The serum level of oestradiol was 249.5 ±142.3 pmol/l in the control and did not differ either in tT3 (377.6 ±133.1) or in cT3 (245.9 ±74.2).

Body and testes weights {#S20011}
-----------------------

[Table I](#T0001){ref-type="table"} shows that body weight did not change after tT3 treatment but was decreased by 11.7% after cT3 when compared with the control group. Relative paired testes weight was 34.7 ±6.2 mg in the control group, increased by 27.9% after tT3 and did not change after cT3.

###### 

Body and relative testes weights in rats receiving vehicle (Control) or triiodothyronine (T3) in transient or continuous experiments

  Parameter                       Control (*n* = 5)   Transient T3 (*n* = 5)                        Continuous T3 (*n* = 5)
  ------------------------------- ------------------- --------------------------------------------- ---------------------------------------------
  Body weight \[g\]               29.3 ±1.45          31.5 ±2.49                                    25.9 ±1.94[a](#TF0001){ref-type="table-fn"}
  Relative testes weight \[mg\]   34.7 ±6.24          44.4 ±3.70[b](#TF0002){ref-type="table-fn"}   33.2 ±2.55

n -- number of animals

p \< 0.01 ANOVA, least significant differences (LSD) as a post hoc test for experimental vs. control group

p \< 0.05 ANOVA, least significant differences (LSD) as a post hoc test for experimental vs. control group

Cx43 expression, seminiferous tubule morphometry and germ cell degeneration {#S20012}
---------------------------------------------------------------------------

In the control group, most of the tubules revealed intense, positive staining for Cx43. The staining was located in the apical adluminal part of the seminiferous epithelium and the tubule lumen was not present yet. Cx43 was expressed in the cytoplasm of Sertoli cells, evidenced by the columnar distribution of staining, a pattern typical for Sertoli cells ([Figures 1 A](#F0001){ref-type="fig"}, [1 B](#F0001){ref-type="fig"}).

![Representative photomicrographs of seminiferous tubule cross-sections in germ cell association 1, immunostained for connexin 43 (Cx43) (brown colour) in rats from the control group (Control: **A, B**), rats treated transiently with T3 (tT3: **C, D**) or continuously (cT3: **E, F**). Note that in Control, all seminiferous tubule cross-sections are Cx43 positive, while in tT3 and cT3 Cx43-positive tubules are less frequently seen (**C, E**). In Control, Cx43 expression is intense and abundant, localized in the adluminal part of Sertoli cell cytoplasm (**A, B**), whereas in tT3 Cx43 immunostaining is localized more peripherally (**C, D**). In cT3 an enlarged tubule lumen (Lu) is associated with vacuolation (V) of Sertoli cell cytoplasm (**E**), and Cx43 immunostaining almost disappeared (**F**)\
S -- Sertoli cell, SgA -- type A spermatogonia, SgB -- type B spermatogonia, ScPA -- pachytene spermatocytes (Bar = 40 μm in A, C, E and bar = 10 μm in B, D, F)](AMS-9-20224-g001){#F0001}

After tT3 treatment, tubule diameter increased, and Cx43 immunostaining disappeared from the adluminal region of Sertoli cell cytoplasm and was localized peripherally in Sertoli cell cytoplasm close to the layer of Sertoli cell nuclei. Most tubules developed a lumen ([Figures 1 C](#F0001){ref-type="fig"}, [1 D](#F0001){ref-type="fig"}).

After cT3 treatment, the seminiferous tubule lumen was the widest one with a distinctly outlined border (Lu) which, together with the short length of seminiferous tubule growth, was suggestive of seminiferous tubule distention. The Sertoli cell cytoplasm became vacuolated. As after tT3 also after cT3, Cx43 immunostaining was absent in the adluminal part of the seminiferous epithelium, but had minimal or almost undetectable expression ([Figures 1 E](#F0001){ref-type="fig"}, [1 F](#F0001){ref-type="fig"}). In 50-day-old adult rats, the incidence of Cx43 positive tubules was 28.9 ±2.5% and Cx43 immunostaining was located superior to the layer of spermatogonia ([Figure 2](#F0002){ref-type="fig"}).

![Representative photomicrographs of seminiferous tubule cross-section immunostained for connexin 43 (Cx43) (brown colour -- arrows) in 50-day-old rats in stage VI of the seminiferous epithelium cycle. The section of the seminiferous tubule marked by a white rectangle in Figure A is magnified in [Figure 2](#F0002){ref-type="fig"}\
SgB -- type B spermatogonia, ScPa -- pachytene spermatocytes, rSd -- round spermatids, eSd -- elongate spermatids, L -- Leydig cells (Bar = 40 μm in A and bar = 10 μm in B)](AMS-9-20224-g002){#F0002}

Seminiferous tubule diameter increased after both tT3 and cT3 ([Figure 3 A](#F0003){ref-type="fig"} ), while the length of seminiferous tubules was reduced after cT3 ([Figure 3 B](#F0003){ref-type="fig"}). The incidence of tubules containing degenerating germ cells was 19.8 ±4.7% in the control group, similar to tT3 (21.3 ±9.0%), but increased to 37.6 ±5.1% in cT3 (1.9-fold of control, *p* \< 0.01) ([Figure 3 C](#F0003){ref-type="fig"}).

![The influence of triiodothyronine after transient (tT3) or continuous (cT3) administration on seminiferous tubule diameter (A), total length (B), the incidence of tubules containing degenerating germ cells (C), and the incidence of tubules positive for Cx43 (D) (mean ± SD)\
C -- control group; Analysis of variance (ANOVA); ^a^p \< 0.001, ^b^p \< 0.01; number of animals in parenthesis](AMS-9-20224-g003){#F0003}

The incidence of tubular cross-sections positive for Cx43 was 86.2 ±8.6% in the control group and was reduced to 46.3 ±9.8% in tT3 (46% less than control, *p* \< 0.001) and to 45.8 ±8.1% in cT3 (47% less than control, *p* \< 0.001) ([Figure 3 D](#F0003){ref-type="fig"}).

Discussion {#S0013}
==========

Transient administration of T3 increased 2.6-fold serum fT3 level, despite discontinuation of the treatment 11 days earlier, while continuous treatment increased serum fT3 12-fold. T3 is prevalent within tissues, has high potency, rapid effects and rapid turnover. Panno *et al*. \[[@CIT0025]\] found that in immature rats serum level of total T3 did not increase on the day that followed 7-day intraperitoneal daily administration of T3. This discrepancy may arise from the different route of administration of T3 (here subcutaneous) and the higher dose applied here (100 µg/kg b.w. instead of 30 µg/kg as applied previously). Indeed, it has been reported that in a hypothyroid woman, erroneous oral intake of an excessive dose of T3 (5 mg of T3 every 8 h) for 9 days resulted in 397 times higher than normal serum level of total T3 after the treatment. The T3 level was normalized 200 h (8.3 days) after the intake of the last dose, and clinical manifestation of toxic effects still lasted 3 days more \[[@CIT0026]\].

While transient treatment increased testes weight and seminiferous tubule diameter, continuous treatment decreased tubule length and increased germ cell degeneration. A decrease in body weight indicated a thyrotoxic effect of high T3 level. Follicle-stimulating hormone (FSH) is responsible for seminiferous tubule growth \[[@CIT0027]\], and it was previously found that in pubertal ram lambs, T3 administration decreased serum levels of FSH \[[@CIT0028]\]. In our study, FSH level did not differ from earlier reports incorporating a rat model \[[@CIT0007]\]. Neither of the treatments influenced serum levels of testosterone or oestradiol, indicating a direct hormonal effect of T3.

We observed that in untreated 16-day-old rats, 86% of seminiferous tubule cross-sections were Cx43-positive. A similar figure has been reported to occur in older rats (at pnd 22-30) where indirect immunofluorescence techniques in frozen sections of the testes were used \[[@CIT0004]\]. Together with an increase in the seminiferous tubule diameter by T3 administration, the incidence of Cx43 positive tubules declined from about 90% to less than 50% and only 29% of tubule cross-sections were Cx43 positive in 50-day-old untreated mature rats. A decrease in the incidence of Cx43-positive tubule cross-section from about 90% to 60% was reported to occur during progression of seminiferous tubule maturation in normal rats \[[@CIT0004], [@CIT0014]\]. Hence our data suggest that maturational changes in Cx43 expression in seminiferous tubules may depend on thyroid hormone action.

We also found that while in the untreated 16-day-old rats Cx43 immunostaining had an apical, adluminal localization in the seminiferous epithelium, it shifted into the periphery after T3 administration. In normal rats, expression of Cx43 undergoes natural dislocation from the apical to the basal part of Sertoli cell cytoplasm from pnd 22 onward \[[@CIT0004], [@CIT0029]\]. A delay of the natural dislocation of Cx43 expression within the cytoplasm of maturating Sertoli cells has been observed in hypothyroid neonatal rats \[[@CIT0029]\]. This suggests that thyroid hormone may be responsible for maturational shift in Cx43 expression localization within the seminiferous epithelium. Pelletier \[[@CIT0030]\] proposed that Cx43 may play a role in the formation at puberty of the blood-testis barrier, a structure that develops in the basal part of Sertoli cell cytoplasm.

In turn, continuous T3 treatment with a high final level of T3 caused immunostaining for Cx43 to be weaker (or almost undetectable) than that found after transient treatment. Seminiferous tubule growth was inhibited, tubules distended, the Sertoli cell cytoplasm had become vacuolated and germ cell degeneration increased, all suggesting a toxic effect of T3. A decrease in seminiferous tubule growth was presumably due to the inhibition of Sertoli cell proliferation, as previously observed after T3 administration in a similar experiment \[[@CIT0007]\]. The vacuolation of Sertoli cell cytoplasm is indicative of a breakdown in Sertoli-germ cell junctions \[[@CIT0031]\]. Tribulova *et al*. \[[@CIT0032]\] demonstrated that although T3 increased the expression of Cx43 in heart myocytes *in vitro*, the exposure to higher concentrations of T3 caused disintegration of sarcomeric β-actin in myocytes, suggesting "overdosage" of T3. T3-induced cardiac thyrotoxicosis was shown to be associated with increased proteolysis in heart myocytes \[[@CIT0033]\]. Thyrotoxicosis-induced increased proteolysis might be a cause of the observed decline in Cx43 expression connected with regressive changes within the seminiferous epithelium.

In conclusion, maturational changes in Cx43 expression within the seminiferous epithelium might arise from the short and transient stimulatory influence of thyroid hormone on testes maturation. In turn, reduced Cx43 expression was associated with regressive changes in seminiferous tubules, which might suggest deprivation of Cx43 activity by the toxic effects of continuously high levels of T3.
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